Matthew Koslow

1.0k total citations · 1 hit paper
28 papers, 607 citations indexed

About

Matthew Koslow is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Matthew Koslow has authored 28 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Matthew Koslow's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Medical Imaging and Pathology Studies (5 papers) and Sarcoidosis and Beryllium Toxicity Research (4 papers). Matthew Koslow is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Medical Imaging and Pathology Studies (5 papers) and Sarcoidosis and Beryllium Toxicity Research (4 papers). Matthew Koslow collaborates with scholars based in United States, Israel and Italy. Matthew Koslow's co-authors include Ryan Clay, Shireen Mirza, Paul D. Scanlon, David Shitrit, Gali Epstein Shochet, Y Levi, Randal S. Stahl, Pauline Nol, Jack C. Rhyan and Kurt C. VerCauteren and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Matthew Koslow

24 papers receiving 593 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

COPD Guidelines: A Review of the 2018 GOLD Report

2018 318 citations Shireen Mirza, Ryan Clay et al. Mayo Clinic Proceedings profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Koslow United States	10	378	143	101	80	71	28	607
Tetsuya Urano Japan	15	347 0.9×	98 0.7×	161 1.6×	60 0.8×	73 1.0×	59	743
Chang Youl Lee South Korea	14	264 0.7×	76 0.5×	68 0.7×	27 0.3×	111 1.6×	65	658
Chun‐Yu Lin Taiwan	15	275 0.7×	95 0.7×	115 1.1×	22 0.3×	122 1.7×	44	639
Varsha Taskar United States	12	644 1.7×	184 1.3×	216 2.1×	27 0.3×	66 0.9×	41	979
Maria Sofia Italy	17	330 0.9×	162 1.1×	101 1.0×	94 1.2×	125 1.8×	60	775
Annlyse Fanton France	9	563 1.5×	90 0.6×	112 1.1×	11 0.1×	73 1.0×	13	717
Karen Hardy United States	12	511 1.4×	151 1.1×	130 1.3×	43 0.5×	127 1.8×	18	802
David S. Chou United States	10	176 0.5×	82 0.6×	48 0.5×	133 1.7×	60 0.8×	16	692
N. Barnes United Kingdom	12	381 1.0×	491 3.4×	97 1.0×	28 0.3×	56 0.8×	31	854
Alessandra Sandrini Australia	16	587 1.6×	529 3.7×	55 0.5×	116 1.4×	47 0.7×	21	1.1k

Countries citing papers authored by Matthew Koslow

Since Specialization

Citations

This map shows the geographic impact of Matthew Koslow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Koslow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Koslow more than expected).

Fields of papers citing papers by Matthew Koslow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Koslow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Koslow. The network helps show where Matthew Koslow may publish in the future.

Co-authorship network of co-authors of Matthew Koslow

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Koslow. A scholar is included among the top collaborators of Matthew Koslow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Koslow. Matthew Koslow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koslow, Matthew, David Baraghoshi, Jeffrey J. Swigris, et al.. (2025). One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease. American Journal of Respiratory and Critical Care Medicine. 211(10). 1775–1784.

Chaudhary, Sachin, Tilman Koelsch, Matthew Koslow, et al.. (2025). Development and validation of a clinical, CT, genomic classifier and BAL scoring system for diagnosing idiopathic pulmonary fibrosis. European Respiratory Journal. 65(3). 2401077–2401077. 1 indexed citations

Koslow, Matthew, et al.. (2024). Manifestations and management of Sjögren’s disease. Arthritis Research & Therapy. 26(1). 43–43. 11 indexed citations

Koslow, Matthew, David A. Lynch, Carlyne D. Cool, Steve D. Groshong, & Gregory P. Downey. (2023). Lymphangioleiomyomatosis and Other Cystic Lung Diseases. Immunology and Allergy Clinics of North America. 43(2). 359–377. 2 indexed citations

Koslow, Matthew, et al.. (2023). Kidney transcriptome and cystic kidney disease genes in zebrafish. Frontiers in Physiology. 14. 1184025–1184025. 4 indexed citations

Koslow, Matthew, David Mondaca‐Ruff, & Xiaolei Xu. (2023). Transcriptome studies of inherited dilated cardiomyopathies. Mammalian Genome. 34(2). 312–322. 2 indexed citations

Pérez, Evans R. Fernández, James Crooks, Jeffrey J. Swigris, et al.. (2021). Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis. ERJ Open Research. 7(2). 54–2021. 2 indexed citations

Koslow, Matthew, et al.. (2021). Diagnosis and Management of Interstitial Lung Disease in Patients with Connective Tissue Diseases. SHILAP Revista de lepidopterología. 2021. 1–7. 4 indexed citations

Baldi, Bruno Guedes, Elżbieta Radzikowska, Vincent Cottin, et al.. (2021). COVID-19 in Lymphangioleiomyomatosis. CHEST Journal. 161(6). 1589–1593. 4 indexed citations

10.

Koslow, Matthew, Eric S. Edell, David E. Midthun, et al.. (2020). Bronchoscopic Cryobiopsy and Forceps Biopsy for the Diagnostic Evaluation of Diffuse Parenchymal Lung Disease in Clinical Practice. SHILAP Revista de lepidopterología. 4(5). 565–574. 14 indexed citations

11.

Koslow, Matthew, Stephanie Griffith‐Richards, Kareem Ahmad, et al.. (2020). A 48-Year-Old South African Woman with Rheumatoid Arthritis and Lung Nodules. CHEST Journal. 157(5). e151–e155. 1 indexed citations

12.

Koslow, Matthew, et al.. (2020). Systemic Thrombolysis Therapy is Associated With Improved Outcomes Among Patients With Acute Pulmonary Embolism and Respiratory Failure. The American Journal of the Medical Sciences. 360(2). 129–136. 1 indexed citations

13.

Koslow, Matthew, David Shitrit, Orit Uziel, et al.. (2019). Peripheral blood telomere alterations in ground glass opacity (GGO) lesions may suggest malignancy. Thoracic Cancer. 10(4). 1009–1015. 2 indexed citations

14.

Koslow, Matthew, Jason R. Young, Eunhee S. Yi, et al.. (2018). Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy. European Radiology. 29(4). 1684–1692. 27 indexed citations

15.

Mirza, Shireen, Ryan Clay, Matthew Koslow, & Paul D. Scanlon. (2018). COPD Guidelines: A Review of the 2018 GOLD Report. Mayo Clinic Proceedings. 93(10). 1488–1502. 318 indexed citations breakdown →

16.

Levi, Y, et al.. (2018). Rheumatological Assessment Is Important for Interstitial Lung Disease Diagnosis. The Journal of Rheumatology. 45(11). 1509–1514. 47 indexed citations

17.

Shochet, Gali Epstein, et al.. (2016). Nintedanib (BIBF 1120) blocks the tumor promoting signals of lung fibroblast soluble microenvironment. Lung Cancer. 96. 7–14. 14 indexed citations

18.

Shitrit, David, et al.. (2015). Increased hypoxemia in patients with COPD and pulmonary hypertension undergoing bronchoscopy with biopsy. International Journal of COPD. 10. 2627–2627. 10 indexed citations

19.

Koslow, Matthew, Rafael Kuperstein, Iris Eshed, et al.. (2014). The Unique Clinical Features and Outcome of Infectious Endocarditis and Vertebral Osteomyelitis Co-infection. The American Journal of Medicine. 127(7). 669.e9–669.e15. 36 indexed citations

20.

Peled, Nir, Radu Ionescu, Pauline Nol, et al.. (2012). Detection of volatile organic compounds in cattle naturally infected with\n<i>Mycobacterium bovis</i>. Insecta mundi. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact